The association between hydroxychloroquine use and future development of systemic lupus erythematosus in patients with primary Sjögren's syndrome.
Bo-Chueh HsuYi-Hsing ChenChing-Heng LinKuo-Tung TangPublished in: International journal of rheumatic diseases (2022)
Nearly 1% of pSS patients may develop SLE. HCQ use in pSS patients was not associated with a lower possibility of the future development of SLE.